Research and analysis

Herpes zoster (shingles) immunisation programme 2021 to 2022: evaluation reports

Evaluation of the eighth year of the shingles vaccination programme in England: financial year 2021 to 2022.

• From: UK Health Security Agency
• Published: 22 February 2022
• Last updated: 11 November 2022
  Show all updates

  1. 11 November 2022

     Added backing data file for the 2021 to 2022 annual report.

  2. 27 October 2022

     Added HPR 16(11) annual report for financial year 2021 to 2022.

  3. 25 May 2022

     Added HPR 16(5) quarterly report and supporting data file.

  4. 4 April 2022

     Added latest report and supporting data.

  5. 22 February 2022

     First published.

Applies to England

Documents

Shingles vaccine coverage (England): annual report of the financial year 2021 to 2022

Ref: HPR 16(11)

HTML

Shingles vaccine coverage for those becoming 70 to 80 years of age in the year 1 April 2021 to 31 March 2022 as of 23 June 2022

Ref: UKHSA publication gateway number GOV-13502; HPR 16(11).

ODS, 114 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage report (adults eligible from April to December 2021 and vaccinated to the end of March 2022): England Quarter 3 of 2021 to 2022

Ref: HPR 16(5)

HTML

Shingles vaccine coverage by CCG, LT and LA for England, April to December 2021 and vaccinated to the end of March 2022): England

Ref: UKHSA publication gateway number GOV-12219; HPR 16(5).

ODS, 144 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage report (adults eligible from April to September 2021 and vaccinated to end of December 2021): England Quarter 2 of 2021 to 2022

Ref: UKHSA publications gateway number GW-11866; HPR 16(3)

PDF, 387 KB, 17 pages

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage by CCG, LT and LA for England, April to September 2021 (vaccinated to end of December 2021)

Ref: UKHSA publication gateway number GOV-11866; HPR 16(3)

MS Excel Spreadsheet, 127 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage report (adults eligible from April to June 2021 and vaccinated to end of September 2021): England Quarter 1 of 2021 to 2022

Ref: UKHSA publications gateway number GOV-11432; HPR 16(3)

PDF, 370 KB, 14 pages

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage by CCG, LT and LA for England, April to June 2021 (vaccinated to end of September 2021)

Ref: UKHSA publications gateway number GOV-11432; HPR 16(3)

MS Excel Spreadsheet, 117 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

For previous reports, published by Public Health England, see shingles vaccine uptake and the archive of older data.